Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Safeplus International Holdings Limited (ACAI : OTC)

• Company Description    Biophan Technologies is engaged in designing, developing, and marketing new technology and related products to enable cardiac pacemakers and other life sustaining medical devices to be safe and compatible with magnetic resonance imaging (MRI) and other equipment using magnetic fields and radio waves. This MRI-compatible technology will be utilized in implantable pacemakers, implantable cardioverter defibrillators, and other medical equipment. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $ Daily Weekly Monthly 20 Day Moving Average: 219 shares Shares Outstanding: 25.38 (millions) Market Capitalization: $ (millions) Beta: 0.66 52 Week High: $0.00 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 15 SCHOEN PLACE - PITTSFORD,NY 14534 USA ph: 585-267-4800 fax: 585-427-2433 info@biophan.com http://www.biophan.com

• General Corporate Information    Officers Stan Yakatan - Chairman John F. Lanzafame - Chief Executive Officer Margaret V. Russell - Chief Financial Officer Theodore A. Greenberg - Director Harold Gubnitsky - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 78646R106 SIC: 3841 Fiscal Year Fiscal Year End: February Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 25.38 Most Recent Split Date: 9.00 (0.01:1) Beta: 0.66 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: % Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 05/31/25 - - 02/28/25 - - 11/30/24 - - ROA 05/31/25 - - 02/28/25 - - 11/30/24 - - Current Ratio 05/31/25 - - 02/28/25 - - 11/30/24 - - Quick Ratio 05/31/25 - - 02/28/25 - - 11/30/24 - - Operating Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Net Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Pre-Tax Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Book Value 05/31/25 - - 02/28/25 - - 11/30/24 - - Inventory Turnover 05/31/25 - - 02/28/25 - - 11/30/24 - - Debt-to-Equity 05/31/25 - - 02/28/25 - - 11/30/24 - - Debt-to-Capital 05/31/25 - - 02/28/25 - - 11/30/24 - -

Powered by Zacks Investment Research ©